Michael H. Cain
University of Wisconsin–Milwaukee
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael H. Cain.
FEBS Letters | 1981
Evan F. Williams; Steven M. Paul; Kenner C. Rice; Michael H. Cain; Phil Skolnick
Ethyl&carboline-3-carboxylate (P-CCE) has been isolated from brain and urine extracts and found to potently inhibit the binding of [3H]benzodiazepines to specific receptor sites in the brain [ 11. Although /3-CCE (or a closely related derivative) was initially postulated to be an endogenous ligand of the benzodiazepine receptor [ 11, subsequent studies strongly suggest [2] that this compound (as well as its methyl ester and 3-carboxylic acid derivatives) is formed artifactually during the extraction and isolation procedures. Nonetheless, the extremely high affinity of @-CCE and related compounds in displacing [3H]benzodiazepines from receptor sites in the central nervous system [3,4] coupled with recent reports that P-CCE and related /3-carbolines are specific antagonists of many of the pharmacologic actions of benzodiazepines [S91, suggests that these compounds may be valuable tools for studying the regulation of the benzodiazepine receptor. cimol) markedly enhanced the apparent affinity of [3H]benzodiazepines for the benzodiazepine receptor [ 111. These observations prompted us to examine the effect of other drugs and anions known to enhance the apparent affinity of [3H]benzodiazepines for benzodiazepine receptors on the binding of /3-[3H]CCE. We now report that in contrast to the changes in affinity of [ 3H] benzodiazepines elicited by halide ions [ 121, barbiturates [ 13151, and pyrazolopyridines [16,17], the apparent affinity of p-[3H]CCE is unaffected by these agents. Furthermore, Scatchard analysis of /3-[3H]CCE binding to cerebral cortical and cerebellar membranes revealed a significantly greater number of binding sites than was observed with either [3H]diazepam or [3H]flunitrazepam, suggesting that at low concentrations benzodiazepines selectively label a subpopulation of the receptors labelled with fl[3H] CCE. Alternatively, p[ 3H] CCE may bind to sites that are distinct from those labelled with [3H]benzodiazepines.
Journal of Medicinal Chemistry | 1985
Ronald E. Weishaar; Michael H. Cain; James A. Bristol
Journal of Medicinal Chemistry | 1982
Michael H. Cain; Robert W. Weber; Fil Guzman; James M. Cook; Steven A. Barker; Kenner C. Rice; Jacqueline N. Crawley; Steven M. Paul; Phil Skolnick
European Journal of Pharmacology | 1981
Phil Skolnick; Steven M. Paul; Jacqueline N. Crawley; Kenner C. Rice; Steven A. Barker; Robert W. Weber; Michael H. Cain; James M. Cook
Journal of Medicinal Chemistry | 1984
Filadelfo Guzman; Michael H. Cain; P. Larscheid; Tim Hagen; James M. Cook; Margaret M. Schweri; Phil Skolnick; Steven M. Paul
Journal of Medicinal Chemistry | 1986
Ila Sircar; Bradley L. Duell; Michael H. Cain; Sandra E. Burke; James A. Bristol
Heterocycles | 1982
James M. Cook; Michael H. Cain; Fil Guzman; Kenner C. Rice; Phil Skolnick
Archive | 1985
Ila Sircar; Michael H. Cain; John G. Topliss
Archive | 1985
Ila Sircar; Michael H. Cain; John G. Topliss
ChemInform | 1985
R. E. Weishaar; Michael H. Cain; James A. Bristol